Generation of IPi001-A/B/C human induced pluripotent stem cell lines from healthy amniotic fluid cells

Generation of IPi001-A/B/C human induced pluripotent stem cell lines from healthy amniotic fluid cells

Human induced Pluripotent Stem Cells (hiPSCs) represent an invaluable source of primary cells to investigate development, establish cell and disease models, provide material for regenerative medicine and allow more physiological high-content screenings. Here, we generated three healthy hiPSC control...

Full description

Bibliographic Details
Main Authors:	Mikaël Boullé, Alix Boucharlat, Ambre Leleu, Céline Banal, Aurélie Coussement, Marcel Hollenstein, Frank Yates, Nathalie Lefort, Fabrice Agou
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Stem Cell Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1873506124000485

Similar Items

Generation of IPi002-A/B/C human induced pluripotent stem cell lines from MARCH amniotic fluid cells
by: Mikaël Boullé, et al.
Published: (2024-12-01)

Generation and characterization of IMAGINi013-A, an induced pluripotent stem cell line generated from a healthy donor
by: Céline Banal, et al.
Published: (2022-05-01)

Generation and characterization of induced pluripotent stem cell lines from two patients with recessive dystrophic epidermolysis Bullosa
by: Camille Vincent, et al.
Published: (2023-06-01)

High-Content RNAi Phenotypic Screening Unveils the Involvement of Human Ubiquitin-Related Enzymes in Late Cytokinesis
by: Mikaël Boullé, et al.
Published: (2022-11-01)

PB2103: CAN WE ACCURATELY PREDICT SURVIVAL IN DIFFUSE LARGE B CELL LYMPHOMA IN THE RITUXIMAB ERA? RETROSPECTIVE COMPARISON OF IPI, AAIPI, R-IPI AND NCCN-IPI
by: P. Chorão, et al.
Published: (2022-06-01)

External validation and comparison of IPI, R-IPI, and NCCN-IPI in diffuse large B-cell lymphoma patients treated with R-CHOP to predict 2-year progression-free survival
by: Naree Warnnissorn, et al.
Published: (2022-12-01)

Pluripotency maintenance of amniotic fluid-derived stem cells cultured on biomaterials
by: Wang, Pin Yu, et al.
Published: (2015)

Generation of induced pluripotent stem cells (iPSCs) from a microvillus inclusion disease patient with a homozygous missense mutation in UNC45A
by: Celine Banal, et al.
Published: (2023-04-01)

IPI: uma abordagem constitucional
by: Guilherme Luis Muramatsu Pereira, et al.
Published: (2009-07-01)

The history of the International Polar Years (IPYs) /
by: Barr, Susan
Published: (c201)

Generation of three induced pluripotent stem cell lines (RAUi001-A, RAUi001-B and RAUi001-C) from peripheral blood mononuclear cells of a healthy Armenian individual
by: Elena V. Grigor’eva, et al.
Published: (2023-09-01)

PRINTsIPY DIAGNOSTIKI RANNEGO REVMATOIDNOGO ARTRITA
by: I B Belyaeva, et al.
Published: (2005-06-01)

Generation of induced pluripotent stem cell GZHMCi001-A and GZHMCi001-B derived from peripheral blood mononuclear cells of epileptic patients with KCNC1 mutation
by: Liu Nengqing, et al.
Published: (2020-08-01)

Naïve pluripotent-like characteristics of non-tumorigenic Muse cells isolated from human amniotic membrane
by: Eiji Ogawa, et al.
Published: (2022-10-01)

Integration-free reprogramming of human umbilical arterial endothelial cells into induced pluripotent stem cells IHSTMi001-A
by: Huilin Li, et al.
Published: (2018-08-01)

Establishment of an induced pluripotent cell line (ABCRIi001-A) from an elderly female for ageing research
by: Filipa Esteves, et al.
Published: (2024-12-01)

Generation of GZKHQi001-A and GZWWTi001-A, two induced pluripotent stem cell lines derived from peripheral blood mononuclear cells of Duchenne muscular dystrophy patients
by: Xie Yuhuan, et al.
Published: (2018-04-01)

Use of integrated pulmonary index (IPI) in clinical practice
by: Serdar Özdemir
Published: (2024-12-01)

Record linkage improves assessment of interpregnancy interval (IPI)
by: Christine Roberts, et al.
Published: (2017-04-01)

Context, Development, and Intent: An Introduction to the IPI Preservation Metrics
by: Emma J. Richardson, et al.
Published: (2023-05-01)

THEORETICAL CONSIDERATIONS AND PRACTICAL APPROACHES FOR CALCULATING IPI AND ICA
by: Mircea BURIAN, et al.
Published: (2010-02-01)

The State of IPY Data Management: The Japanese Contribution and Legacy
by: K Kanao, et al.
Published: (2013-03-01)

Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach
by: Moschidou, D., et al.
Published: (2012)

Long-term real-world (RW) outcomes in patients with advanced melanoma (MEL) treated with ipilimumab (IPI) and non-IPI therapies: IMAGE study
by: Dalle, S, et al.
Published: (2019)

Generation of induced pluripotent stem cells (ZZUCSBi001-A) from skin fibroblasts of a healthy donor
by: Shu-Ang Li, et al.
Published: (2024-04-01)

Generation of an induced pluripotent stem cell lines NSHDMUi001-A from patients with type 2 diabetes
by: Peixue Li, et al.
Published: (2023-06-01)

Amniotic Fluid and Amniotic Membrane Stem Cells: Marker Discovery
by: Maria G. Roubelakis, et al.
Published: (2012-01-01)

Lithocholic Acid Alleviates Deoxynivalenol-Induced Lethal Cholesterol Metabolic Abnormalities in IPI-2I Cells
by: Yanwei Li, et al.
Published: (2022-07-01)

Self-renewal of acute lymphocytic leukemia cells is limited by the Hedgehog pathway inhibitors cyclopamine and IPI-926.
by: Tara L Lin, et al.
Published: (2010-12-01)

OBShchIE PRINTsIPY LEChENIYa ANTIFOSFOLIPIDNOGO SINDROMA
by: A E Dorokhov, et al.
Published: (2005-06-01)

PRINTsIPY KhIRURGIChESKOGO LEChENIYa OSTEOARTROZA
by: I. V. Devin, et al.
Published: (2005-06-01)

O creditamento do IPI sob a perspectiva jurisprudencial
by: Eliane Demétrio, et al.
Published: (2009-12-01)

Establishment of an induced pluripotent stem cell line (SDCHi001-A) from a healthy Chinese child donor
by: Ling Wang, et al.
Published: (2024-02-01)

Generation of a human induced pluripotent stem cell line CERAi001-A-6 using episomal vectors
by: Raymond C.B. Wong, et al.
Published: (2017-07-01)

Generation of human induced pluripotent stem cell line (WMUi001-A) from a patient with aortic dissection
by: Peifeng Jin, et al.
Published: (2020-03-01)

Generation of human induced pluripotent stem cell (DMSCi001-A) line from hematopoietic stem cells of a healthy female donor
by: Sudarat Wongkidakarn, et al.
Published: (2024-12-01)

Generation of a human induced pluripotent stem cell line (SYSUTFi001-A) from infiltrating cytotoxic T cells in hepatocellular carcinoma (HCC)
by: Daopeng Yang, et al.
Published: (2022-12-01)

Generation of an induced pluripotent stem cell line (BIORTCi001-A) from a healthy adult indigenous Nigerian participant
by: Zaid Muhammad, et al.
Published: (2024-10-01)

Generation of a control induced pluripotent stem cell line (SDUCHi001-A) from a healthy male donor
by: Chunmiao Li, et al.
Published: (2024-06-01)

Production and characterization of human induced pluripotent stem cells (iPSCs) from Joubert Syndrome: CSSi001-A (2850)
by: Jessica Rosati, et al.
Published: (2018-03-01)